USANA Health Sciences Inc (USNA) Stock Price

USNAStock

$13.78−57.88%52W

Market Cap$254.61M

P/E25.06x

PEG Ratio1.04

Div yield—

Beta0.70

USNA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.77%

Price vs S&P 500 (4W)-44.62%

PEG Ratio1.04

VGM Score42.16

P/E Ratio (Annual)25.06x

P/CF (Annual)12.07x

Book Value / Share (Quarterly)$29.45

P/TBV (Annual)0.87x

Revenue Growth (3Y)-2.51%

Cash Flow / Share (Quarterly)$0.16

Price vs S&P 500 (YTD)-42.78%

Gross Margin (TTM)77.55%

Net Profit Margin (TTM)0.96%

EPS (TTM)$0.48

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$0.48

Revenue Growth (5Y)-4.00%

EPS (Annual)$0.58

ROI (Annual)1.97%

Gross Margin (Annual)78.29%

Net Profit Margin (5Y Avg)5.96%

Cash / Share (Quarterly)$8.82

P/E Basic Excl Extra (TTM)30.39x

Revenue Growth QoQ (YoY)0.27%

EPS Growth (5Y)-37.04%

P/E Normalized (Annual)25.06x

ROA (Last FY)1.45%

Revenue Growth TTM (YoY)5.67%

EBITD / Share (TTM)$3.71

ROE (5Y Avg)13.64%

Operating Margin (TTM)3.85%

Cash Flow / Share (Annual)$0.47

P/B Ratio0.50x

P/B Ratio (Quarterly)0.59x

Net Income / Employee (Annual)$6,900

EV / Revenue (TTM)0.13x

Net Interest Coverage (TTM)103.00x

ROA (TTM)1.21%

EPS Growth QoQ (YoY)-17.13%

EV / EBITDA (TTM)1.77x

EPS Incl Extra (Annual)$0.58

Current Ratio (Annual)2.24x

Quick Ratio (Quarterly)1.47x

3-Month Avg Trading Volume0.14M

52-Week Price Return-57.88%

EV / Free Cash Flow (Annual)14.18x

P/E Incl Extra (TTM)30.39x

Revenue / Employee (TTM)$589,800

Tangible BV / Share (Quarterly)$22.47

P/S Ratio (Annual)0.29x

Asset Turnover (Annual)1.25x

52-Week High$32.32

Operating Margin (5Y Avg)9.41%

EPS Excl Extra (Annual)$0.58

CapEx CAGR (5Y)-1.75%

Tangible BV CAGR (5Y)-0.54%

26-Week Price Return-28.53%

Quick Ratio (Annual)1.35x

13-Week Price Return-26.83%

Total Debt / Equity (Annual)0.03x

Current Ratio (Quarterly)2.51x

Enterprise Value$120.94M

Revenue / Share Growth (5Y)-1.33%

Asset Turnover (TTM)1.26x

Book Value / Share Growth (5Y)6.75%

Revenue / Employee (Annual)$589,300

Inventory Turnover (Annual)2.46x

Pretax Margin (Annual)4.49%

Cash / Share (Annual)$8.66

3-Month Return Std Dev80.81%

Gross Margin (5Y Avg)80.49%

Net Income / Employee (TTM)$5,700

EBITDA CAGR (5Y)-18.12%

EBITDA Interim CAGR (5Y)-14.11%

ROE (Last FY)2.02%

Net Interest Coverage (Annual)50.22x

EPS Basic Excl Extra (Annual)$0.58

P/FCF (TTM)18.85x

Receivables Turnover (TTM)248.40x

EV / Free Cash Flow (TTM)40.84x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$0.48

Receivables Turnover (Annual)326.57x

ROI (TTM)1.64%

P/S Ratio (TTM)0.29x

Pretax Margin (5Y Avg)9.96%

Revenue / Share (Annual)$49.81

Tangible BV / Share (Annual)$21.88

Forward P/E17.73x

Free OCF CAGR (5Y)-43.29%

Price vs S&P 500 (52W)-76.19%

P/E Ratio (TTM)30.39x

EPS Growth TTM (YoY)-73.96%

Year-to-Date Return-30.82%

5-Day Price Return2.80%

EPS Normalized (Annual)$0.58

ROA (5Y Avg)9.79%

Net Profit Margin (Annual)1.16%

Month-to-Date Return-38.58%

Cash Flow / Share (TTM)$3.77

EBITD / Share (Annual)$3.77

EPS Growth (3Y)-45.59%

Operating Margin (Annual)4.05%

LT Debt / Equity (Annual)0.09x

P/CF (TTM)16.22x

ROI (5Y Avg)13.56%

P/E Excl Extra (TTM)30.39x

LT Debt / Equity (Quarterly)0.27x

EPS Basic Excl Extra (TTM)$0.48

P/TBV (Quarterly)0.78x

P/B Ratio (Annual)0.65x

Inventory Turnover (TTM)2.45x

Pretax Margin (TTM)4.35%

Book Value / Share (Annual)$29.16

Price vs S&P 500 (13W)-29.63%

Net Margin Growth (5Y)-36.22%

Beta0.70x

P/FCF (Annual)31.63x

Revenue / Share (TTM)$50.29

ROE (TTM)1.66%

52-Week Low$12.57

vGradeB

gGradeD

mGradeD

vgmGradeC

USNA Earnings Surprise History

Q2 250.74est. 0.54

Q3 25-0.15est. -0.15

Q4 250.60est. 0.41

Q1 260.61est. 0.44

Q2 26-0.07est. 0.43

USNA Analyst Recommendations

Mar 2025

Apr 2025

May 2025

Jun 2025

2.17

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
USNAUSANA Health Sciences Inc	B	D	D	$13.78
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$44.81
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	F	$5.54
TRLVTrulieve Cannabis Corp.	B	C	A	$11.32
CRONCronos Group Inc. Common Share	C	B	B	$3.51
GLASGlass House Brands Inc.	C	C	C	$10.13
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.88
CGCCanopy Growth Corporation Common Shares	B	C	C	$1.07
SNDLSundial Growers Inc. Common Shares	A	C	C	$1.37
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.27
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.97
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$10.05
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.58
NAIINatural Alternatives International Inc.	A	C	D	$2.17
MTEXMannatech Inc.	B	D	C	$6.45
BONBon Natural Life Limited Class A Ordinary Shares	B	D	D	$1.14
AKANAkanda Corp. Common Shares	C	F	F	$4.95
IMCCIM Cannabis Corp. Common Shares	A	B	F	$0.11
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	F	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	D	$23.68

About USANA Health Sciences Inc

USANA Health Sciences Inc develops and manufactures science-based nutritional, personal care, and skincare products focused on long-term health and wellness. The company operates through two segments: direct selling, which generates the majority of revenue across multiple geographic markets, and Hiya, a direct-to-consumer children's health brand in the U.S. These dual channels allow USANA to reach both adult and pediatric wellness markets globally.